Loading, please wait...
:

product description page

Statistical Methods for Immunogenicity Assessment (Hardcover) (Harry Yang & Jianchun Zhang & Binbing Yu

Statistical Methods for Immunogenicity Assessment (Hardcover) (Harry Yang & Jianchun Zhang & Binbing Yu - image 1 of 1

About this item

Develop Effective Immunogenicity Risk Mitigation Strategies

Immunogenicity assessment is a prerequisite for the successful development of biopharmaceuticals, including safety and efficacy evaluation. Using advanced statistical methods in the study design and analysis stages is therefore essential to immunogenicity risk assessment and mitigation strategies. Statistical Methods for Immunogenicity Assessment provides a single source of information on statistical concepts, principles, methods, and strategies for detection, quantification, assessment, and control of immunogenicity.

The book first gives an overview of the impact of immunogenicity on biopharmaceutical development, regulatory requirements, and statistical methods and strategies used for immunogenicity detection, quantification, and risk assessment and mitigation. It then covers anti-drug antibody (ADA) assay development, optimization, validation, and transfer as well as the analysis of cut point, a key assay performance parameter in ADA assay development and validation. The authors illustrate how to apply statistical modeling approaches to establish associations between ADA and clinical outcomes, predict immunogenicity risk, and develop risk mitigation strategies. They also present various strategies for immunogenicity risk control. The book concludes with an explanation of the computer codes and algorithms of the statistical methods.

A critical issue in the development of biologics, immunogenicity can cause early termination or limited use of the products if not managed well. This book shows how to use robust statistical methods for detecting, quantifying, assessing, and mitigating immunogenicity risk. It is an invaluable resource for anyone involved in immunogenicity risk assessment and control in both non-clinical and clinical biopharmaceutical development.

Number of Pages: 237
Genre: Mathematics, Medical
Sub-Genre: Pharmacy, Probability + Statistics / General, Biostatistics
Series Title: Chapman & Hall/CRC Biostatistics
Format: Hardcover
Publisher: Taylor & Francis
Author: Harry Yang & Jianchun Zhang & Binbing Yu & Wei Zhao
Language: English
Street Date: September 3, 2015
TCIN: 50130714
UPC: 9781498700344
Item Number (DPCI): 248-01-5774
If the item details above aren’t accurate or complete, we want to know about it. Report incorrect product info.

Guest reviews

Prices, promotions, styles and availability may vary by store & online. See our price match guarantee. See how a store is chosen for you.